155 related articles for article (PubMed ID: 354127)
1. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
Wood ML; Monaco AP
Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
[No Abstract] [Full Text] [Related]
2. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
Wood ML; Monaco AP
J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
[TBL] [Abstract][Full Text] [Related]
3. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum.
Kilshaw PJ; Brent L; Thomas AV
Transplantation; 1974 Jan; 17(1):57-69. PubMed ID: 4148889
[No Abstract] [Full Text] [Related]
4. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
Bobbio SA; Wood ML; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
[No Abstract] [Full Text] [Related]
5. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
[No Abstract] [Full Text] [Related]
6. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice.
De Fazio SR; Kowolenko M; Monaco AP; Gozzo JJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):547-8. PubMed ID: 2856297
[No Abstract] [Full Text] [Related]
7. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
Monaco AP; Liegeois A; Wood ML; Clark AW
Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
[No Abstract] [Full Text] [Related]
8. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
[No Abstract] [Full Text] [Related]
9. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
Gozzo JJ; Wood ML; Pompei R; Monaco AP
Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
[No Abstract] [Full Text] [Related]
10. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
Wood ML; Heppner G; Gozzo JJ; Monaco AP
Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
[No Abstract] [Full Text] [Related]
12. Reduction of GvH splenomegaly in mice by antilymphocyte serum (ALS): correlation of the effect with immunosuppressive potency of ALS.
Mazuran R; Volić B; Silobrcić V
Z Immunitatsforsch Exp Klin Immunol; 1974 Sep; 147(4):378-83. PubMed ID: 4157053
[No Abstract] [Full Text] [Related]
13. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
Gozzo JJ; Kowolenko M
Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
[No Abstract] [Full Text] [Related]
14. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
Maki T; Gottschalk R; Wood ML; Monaco AP
J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
[TBL] [Abstract][Full Text] [Related]
15. Use of posttransplant-administered peripheral blood lymphocytes for prolonging allograft survival in ALS-treated mice.
Gozzo JJ; Monaco AP; De Fazio SR
Transplant Proc; 1989 Feb; 21(1 Pt 1):269-70. PubMed ID: 2650116
[No Abstract] [Full Text] [Related]
16. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769
[TBL] [Abstract][Full Text] [Related]
17. Influence of immunosuppression on the growth of transplants of spontaneous mammary tumours in mice.
Gruntenko EV
Folia Biol (Praha); 1973; 19(6):414-9. PubMed ID: 4778992
[No Abstract] [Full Text] [Related]
18. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
19. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
[No Abstract] [Full Text] [Related]
20. Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice.
Wood ML; Gottschalk R; Monaco AP
Transplantation; 1980 Apr; 29(4):320-3. PubMed ID: 6445103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
